Sodium 5-ethyl-4,6-dioxo-5-[(2R)-2-pentanyl]-1,4,5,6-tetrahydro-2 -pyrimidinolate

Suppliers

Names

[ CAS No. ]:
21642-83-1

[ Name ]:
Sodium 5-ethyl-4,6-dioxo-5-[(2R)-2-pentanyl]-1,4,5,6-tetrahydro-2 -pyrimidinolate

Chemical & Physical Properties

[ Molecular Formula ]:
C11H17N2NaO3

[ Molecular Weight ]:
248.25400

[ Exact Mass ]:
248.11400

[ PSA ]:
85.08000

[ LogP ]:
1.60930

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CQ6200000
CHEMICAL NAME :
Barbituric acid, 5-ethyl-5-(1-methylbutyl)-, sodium salt, R(+)-
CAS REGISTRY NUMBER :
21642-83-1
LAST UPDATED :
198909
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C11-H18-N2-O3.Na
MOLECULAR WEIGHT :
249.30
WISWESSER LINE NOTATION :
T6VMVNV FHJ FY3&1 F2 &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
110 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JACSAT Journal of the American Chemical Society. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1879- Volume(issue)/page/year: 56,1772,1934
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
204 mg/kg
TOXIC EFFECTS :
Behavioral - general anesthetic Behavioral - excitement
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 26,495,1973
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
162 mg/kg
TOXIC EFFECTS :
Behavioral - general anesthetic Behavioral - excitement
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 26,495,1973

Related Compounds

  • 3,4,5-trimethoxy-N-[2-(pyridin-3-yl)-1H-benzimidazol-5-yl]benzamide
  • [4-(5-methyl-1H-tetrazol-1-yl)phenyl][4-(pyridin-2-yl)piperazin-1-yl]methanone
  • 1-cyclopentyl-N-(2-fluorobenzyl)-6-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxamide
  • 2-[3-(2-chlorophenyl)-6-oxopyridazin-1(6H)-yl]-N-[(2E)-5-cyclohexyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
  • 2-[3-(2-chlorophenyl)-6-oxopyridazin-1(6H)-yl]-N-[(2Z)-4-methyl-1,3-thiazol-2(3H)-ylidene]acetamide
  • 3-[6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-N-(2-methoxybenzyl)propanamide
  • 2-(5-bromo-1H-indol-1-yl)-1-{4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]piperazin-1-yl}ethanone
  • N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-2-(pyridin-4-yl)-1,3-thiazole-5-carboxamide
  • Ethyl 2-{[(1-tert-butyl-5-oxopyrrolidin-3-yl)carbonyl]amino}-1,3-thiazole-4-carboxylate
  • 2-(6-oxo-3-phenylpyridazin-1(6H)-yl)-N-[(2Z)-4-(pyridin-3-yl)-1,3-thiazol-2(3H)-ylidene]acetamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.